1-2 of 2
Carla Tuttle, RN
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Study of Cladribine and Low-Dose Cytarabine (AraC) Alternating with Decitabine in Older Patients with Acute Myeloid Leukemia (AML)

Tapan Kadia, MD, Gautam Borthakur, MD, Alessandra Ferrajoli, MD, Naval Daver, MD, Elias Jabbour, MD, Naveen Pemmaraju, MD, Srdan Verstovsek, MD PhD, Jan A. Burger, MD PhD, William G. Wierda, MD PhD, Marina Konopleva, MD PhD, Courtney D. DiNardo, MD, Nitin Jain, MD, Mark Brandt, Carla Tuttle, RN, Xuemei Wang, PhD, Farhad Ravandi, MD, Guillermo Garcia-Manero, MD, Jorge E. Cortes, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2014) 124 (21): 3671.
https://doi.org/10.1182/blood.V124.21.3671.3671
Published: 2014
Journal Articles

Phase II Trial Of Cladribine and Low-Dose AraC (LDAC) Alternating With Decitabine In Older Patients With Acute Myeloid Leukemia (AML)

Tapan M. Kadia, MD, Gautam Borthakur, MD, Alessandra Ferrajoli, MD, Preetesh Jain, MD, DM, PhD, Elias Jabbour, MD, Srdan Verstovsek, MD, PhD, Naveen Pemmaraju, MD, Stefan Faderl, MD, Farhad Ravandi, MD, Marina Konopleva, MD, PhD, Carla Tuttle, RN, Mark Brandt, Xuemei Wang, MS, Guillermo Garcia-Manero, MD, Hagop M. Kantarjian, MD, Jorge E. Cortes, MD
Journal: Blood
Blood (2013) 122 (21): 5011.
https://doi.org/10.1182/blood.V122.21.5011.5011
Published: 2013